Seeing Is Believing
Currently out of the existing stock ratings of John Ransom, 214 are a BUY (91.45%), 1 are a SELL (0.43%), 19 are a HOLD (8.12%).
Analyst John Ransom, currently employed at RAYMOND JAMES, carries an average stock price target met ratio of 68.03% that have a potential upside of 42.8% achieved within 268 days.
John Ransom’s has documented 425 price targets and ratings displayed on 26 stocks. The coverage is on Healthcare, Consumer Cyclical, Financial Services sectors.
Most recent stock forecast was given on SCI, Service International at 01-Nov-2024.
Analyst best performing recommendations are on CANO (CANO HEALTH).
The best stock recommendation documented was for DVA (DAVITA HEALTHCARE PARTNERS) at 11/28/2017. The price target of $65 was fulfilled within 8 days with a profit of $6.52 (11.15%) receiving and performance score of 13.94.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
$90
$47.98 (114.18%)
$90
1 months 1 days ago
(04-Oct-2024)
2/11 (18.18%)
$34.2 (61.29%)
133
Buy
$76
$33.98 (80.87%)
$83
1 months 6 days ago
(30-Sep-2024)
2/10 (20%)
$12.59 (19.85%)
304
Buy
$94
$51.98 (123.70%)
$94
1 months 16 days ago
(20-Sep-2024)
0/6 (0%)
$17.6 (23.04%)
Hold
$75
$32.98 (78.49%)
$68
3 months 3 days ago
(02-Aug-2024)
9/9 (100%)
$2.63 (3.63%)
95
Buy
$91
$48.98 (116.56%)
$101
5 months 19 days ago
(17-May-2024)
1/4 (25%)
$24.65 (37.15%)
70
Which stock is John Ransom is most bullish on?
Which stock is John Ransom is most reserved on?
What Year was the first public recommendation made by John Ransom?